Sun, Sep 03, 2006 - Page 6 News List

Drug-resistant TB killed 52 in the last year in South Africa


A new, deadly strain of tuberculosis (TB) has killed 52 of 53 people infected in the last year in South Africa, the WHO said on Friday, calling for improved measures to treat and diagnose the bacteria.

The strain was discovered in the Kwazulu-Natal region of South Africa, and is classified as extremely drug-resistant. Drugs from two of the six second-line medicines, used as a last defense against TB, proved ineffective against the new strain.

"We are extremely worried about the issue of extreme drug resistance," said Paul Nunn, coordinator of the WHO's drug resistance department.

"If countries don't have the diagnostic capacity to find these patients, they will die without proper treatment," he said.

Though even the most drug-resistant strains of TB have proven to be treatable with three other classes of drugs, those drugs are more expensive and are toxic to the human body.

The WHO and its partners, including the South African Medical Research Council and the US Center for Disease Control and Prevention, planned a two-day meeting next week in South Africa to discuss the new TB strain in Africa and to find better ways to diagnose and treat it, Nunn said.

Tuberculosis is a respiratory illness spread by coughing and sneezing. Nearly 2 billion people worldwide are thought to be infected with it to some degree.

High mortality rates among TB patients in South Africa, however, prompted medical researchers to survey the cases, resulting in the discovery of the new strain.

Drug resistance is a common problem in TB treatment, but the new strain appears particularly virulent.

"Genetic processes are constantly throwing up mutations of tuberculosis, so this may have arisen due to some particular quirk of the environment or the way they were treated or their genetic background," said Paul Fine, a professor in the field of communicable diseases at the London School of Hygiene and Tropical Medicine.

In general, drug-resistant bacteria are not as easily transmitted as those that are drug-sensitive.

Worldwide, about 2 percent of drug-resistant TB cases are classified as being extremely drug-resistant. Little information is available on extreme drug resistance in Africa, but it is believed to be increasing.

The high prevalence of HIV/AIDS in Africa also complicates the issue of treating extremely drug-resistant TB.

"It's urgent to make the diagnosis when HIV is involved, because if you don't make it, the combination of HIV and TB will kill," Nunn said.

This story has been viewed 4422 times.

Comments will be moderated. Keep comments relevant to the article. Remarks containing abusive and obscene language, personal attacks of any kind or promotion will be removed and the user banned. Final decision will be at the discretion of the Taipei Times.

TOP top